A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil
Open Access
- 12 March 1999
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 79 (11) , 1864-1869
- https://doi.org/10.1038/sj.bjc.6690297
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Thymidylate Synthase Expression and Response to Neoadjuvant Chemotherapy in Patients With Advanced Head and Neck CancerJNCI Journal of the National Cancer Institute, 1997
- p53 Mutation and Locoregional Treatment Failure in Head and Neck Squamous Cell CarcinomaJNCI Journal of the National Cancer Institute, 1996
- Structure and Function of the p53 Tumor Suppressor Gene: Clues for Rational Cancer Therapeutic StrategiesJNCI Journal of the National Cancer Institute, 1996
- Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III TrialJNCI Journal of the National Cancer Institute, 1996
- The role of thymidylate synthase in cellular regulationAdvances in Enzyme Regulation, 1996
- A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracilEuropean Journal Of Cancer, 1994
- Head and Neck CancerNew England Journal of Medicine, 1993
- Overview of Combined Modality Therapies for Head and Neck CancerJNCI Journal of the National Cancer Institute, 1993
- EGFR and PCNA experession in oral squamous cell carcinomas—a valuable tool in estimating the patient's prognosisOral Oncology, 1993
- Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomasHead & Neck, 1991